Join Our Community

Stay in touch with NCPA and your peers in community pharmacy on all of your favorite social networking issues.

Pharmacy Agenda

Men Talking at a Pharmacy 

Address Severe Price Spikes in Generic Medications

We continue to receive complaints from our members about drastic increases in the acquisition price for generic prescription products and importantly, the substantial delays in the updating of the MAC prices for those products. We can’t go into detail at this time regarding the work we are doing to address this problem, but know we are hearing you and we are at work.

Oppose Exclusionary Preferred Pharmacy Networks

Medicare officials, 19 US Senators, 31 US Representatives and outside groups such as Medpac have raised serious questions as to whether preferred pharmacy networks are cost effective. In fact, a CMS analysis of 2012 preferred network plans found they are sometimes more costly than traditional plans. The best solution, which CMS has itself endorsed, to encourage price competition and lower costs is to allow any legitimate pharmacy provider that is willing to accept a health plan’s terms and conditions, including reimbursement, to participate in that plan’s network, whether it is a preferred network or a traditional one.

Expand the Role of Pharmacists in Patient Care

Pharmacists help improve prescription medication use and improve public health by providing counseling, medication therapy management programs, and immunizations. They can also improve quality and reduce medication costs through participation in new patient care delivery models such as Accountable Care Organizations, transition of care models, and chronic care management programs. Policymakers should consider expanding these pharmacist patient care services by designating pharmacists as Medicare Part B providers. Additionally, policymakers should support bipartisan legislation to expand Medication Therapy Management (MTM) services to Medicare patients to promote adherence and reduce costs.

Protect Pharmacy Compounding

Congress recently passed legislation addressing pharmacy compounding. Thanks to grassroots efforts by NCPA members, the legislation maintains state board of pharmacy oversight over this practice. As the legislation is implemented through the federal rule making process, NCPA will remain heavily engaged with the US Food and Drug Administration to ensure the rules adopted to not exceed Congressional intent.

 

Do you have questions? Call NCPA’s government affairs department at (703) 683-8200.